Biotalys NV
XBRU:BTLS
Biotalys NV
XBRU:BTLS
Price:
2.5
EUR
0.4%
Market Closed
Market Cap:
€93.9m
Balance Sheet
Balance Sheet Decomposition
Biotalys NV
Biotalys NV
Balance Sheet Decomposition is not available for
Biotalys NV
Biotalys NV
Balance Sheet
Biotalys NV
Biotalys NV
Currency: EUR
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
23
|
23
|
56
|
34
|
22
|
23
|
|
| Cash Equivalents |
23
|
23
|
56
|
34
|
22
|
23
|
|
| Short-Term Investments |
0
|
2
|
2
|
2
|
2
|
2
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
1
|
|
| Total Current Assets |
24
|
26
|
59
|
38
|
25
|
26
|
|
| PP&E Net |
2
|
9
|
9
|
9
|
8
|
7
|
|
| PP&E Gross |
0
|
0
|
9
|
9
|
8
|
7
|
|
| Accumulated Depreciation |
0
|
0
|
3
|
5
|
6
|
8
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
2
|
3
|
3
|
|
| Total Assets |
28
N/A
|
36
+32%
|
70
+94%
|
50
-30%
|
37
-26%
|
37
+0%
|
|
| Liabilities | |||||||
| Accounts Payable |
2
|
3
|
3
|
3
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
4
|
2
|
1
|
1
|
2
|
1
|
|
| Total Current Liabilities |
6
|
6
|
5
|
6
|
6
|
5
|
|
| Long-Term Debt |
1
|
4
|
6
|
5
|
5
|
4
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Liabilities |
6
N/A
|
11
+65%
|
11
+7%
|
11
+0%
|
11
-3%
|
9
-17%
|
|
| Equity | |||||||
| Common Stock |
48
|
63
|
82
|
45
|
46
|
6
|
|
| Retained Earnings |
27
|
38
|
54
|
17
|
36
|
7
|
|
| Additional Paid In Capital |
1
|
1
|
31
|
10
|
15
|
29
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
21
N/A
|
26
+22%
|
59
+130%
|
38
-35%
|
26
-33%
|
28
+8%
|
|
| Total Liabilities & Equity |
28
N/A
|
36
+32%
|
70
+94%
|
50
-30%
|
37
-26%
|
37
+0%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
30
|
30
|
31
|
31
|
32
|
37
|
|
Switch to:
Switch to:
See Also
Discover More
